Table 2.
Demographics of the population.
| Characteristics | n (%) |
|---|---|
| Sex | |
| Male | 30 (48%) |
| Female | 33 (52%) |
| Age median (range) | 76 years (70–92) |
| Partner status | |
| Widow(er) | 16 (25%) |
| Current partner | 43 (68%) |
| Impaired in basic activities of daily living | 15 (24%) |
| Impaired in instrumental activities of daily living | 21 (33%) |
| No walking aid | 43 (68%) |
| Charlson Comorbidity Index (in addition to cancer) | 1 (0–6) |
| Education | |
| University or higher education | 29 (46%) |
| Vocational training | 11 (17%) |
| Primary/secondary education or less | 8 (13%) |
| Missing | 15 (24%) |
| Types of cancer | |
| Breast cancer | 16 (25%) |
| Multiple myeloma | 10 (16%) |
| Prostate cancer | 9 (14%) |
| Chronic Lymphocytic | 4 (6%) |
| Chronic lymphocytic leukaemia | |
| Lymphoma (various types) | 7 (11%) |
| Ovarian cancer | 3 (5%) |
| Colorectal cancer | 9 (14%) |
| Other gastrointestinal tumours | 5 (8%) |
| Disease stage | |
| Stage I | 9 (14%) |
| Stage II | 4 (6%) |
| Stage III | 9 (14%) |
| Stage IV | 27 (43%) |
| Other (hematologic) | 14 (22%) |
| Received treatment (multiple options per patient possible) | |
| Chemotherapy | 42 (67%) |
| Surgery | 26 (41%) |
| Targeted therapy | 21 (33%) |
| Immunotherapy | 18 (29%) |
| Hormone therapy | 18 (29%) |
| Radiation therapy | 17 (27%) |
| Corticosteroids | 17 (27%) |